NanoValent Pharmaceuticals, Inc.

Address

910 Technology BLVD STE G
Bozeman, MT, 59718-4012

Information

DUNS: 788166986
# of Employees: 2

Ownership Information

Hubzone Owned: Y
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Nanoparticle Delivery System for Ewing Sarcoma Treatment

    Amount: $240,750.00

    DESCRIPTION provided by applicant This Phase I STTR project seeks to demonstrate proof of principle that novel targetable nanoparticles can delivery therapeutic substances to human tumor cells and ...

    STTRPhase I2016Department of Health and Human Services
  2. Targeted Polymerized Shell Microbubbles to Image Surgical Adhesions

    Amount: $238,728.00

    DESCRIPTION provided by applicant The long term goal of this Phase I STTR project is to develop a commercially viable ultrasound contrast reagent UCR that will allow the noninvasive identificatio ...

    STTRPhase I2016Department of Health and Human Services
  3. SBIR Phase II: Targeted Nanoparticle Delivery Agent for Treatment of Adult Leukemia

    Amount: $300,000.00

    This Small Business Innovation Research Phase II project will develop targeted nanoparticle delivery systems capable of delivering conventional cytotoxics preferentially to tumor cells. While therapeu ...

    SBIRPhase II2013National Science Foundation
  4. SBIR Phase I: Targeted Nanoparticle Delivery Agent for Treatment of Adult Leukemia

    Amount: $149,848.00

    This Small Business Innovation Research (SBIR) Phase I project aims to explore the application of a targeted nanodelivery system for both treatment and efficacy monitoring in patients with adult leuke ...

    SBIRPhase I2012National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government